LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 317

Search options

  1. Article ; Online: The HLA-G Genetic Contribution to Bipolar Disorder: A Trans-Ethnic Replication.

    Sundaresh, Aparna / Wu, Ching-Lien / Chinnadurai, Raj Kumar / Rajkumar, Ravi Philip / Mariaselvam, Christina Mary / LeMaoult, Joël / Krishnamoorthy, Rajagopal / Leboyer, Marion / Negi, Vir Singh / Tamouza, Ryad

    Immunological investigations

    2018  Volume 47, Issue 6, Page(s) 593–604

    Abstract: ... the genetic diversity of the immuno-modulatory human leukocyte antigen (HLA)-G locus in a French BD cohort ... The present study investigated the genetic and expression diversities of HLA-G in a geographically distinct ... Toxoplasma gondii pathogen. Three functionally relevant HLA-G polymorphisms, i.e. HLA-G 14 bp Ins/Del (rs66554220 ...

    Abstract Bipolar disorder (BD) is frequently associated with immune dysfunctions. Studying the genetic diversity of the immuno-modulatory human leukocyte antigen (HLA)-G locus in a French BD cohort, we previously reported an association between a functionally relevant 14 bp Ins/Del polymorphism and BD risk. The present study investigated the genetic and expression diversities of HLA-G in a geographically distinct South Indian population-group BD patients, as well as the influence of exposure to the neurotropic Toxoplasma gondii pathogen. Three functionally relevant HLA-G polymorphisms, i.e. HLA-G 14 bp Ins/Del (rs66554220), +3142G>C (rs1063320) and +3187A>G (rs9380142) were genotyped by polymerase chain reaction (PCR) and real-time PCR. Sub-samples of BD patients and healthy controls (HC) were investigated for plasma levels of soluble HLA-G (sHLA-G) isoforms, as well as circulating stigma of T. gondii infection. Findings indicate: (i) the frequency of the HLA-G 14 bp Del/Del genotype was higher in BD cases, as compared to HC; (ii) the HLA-G + 3142 C allele and CC genotype were more prevalent in BD patients than in HC; (iii) sHLA-G levels were significantly higher in BD cases, especially in females and in the early onset sub-group; and (iv) the InsGA haplotype was more prevalent in HC. Our findings further support the genetic contribution of HLA-G to BD risk, as well as indicate relevant expression profiles. Such data may also indicate a potential developmental role in BD etiology, given that HLA-G is an important immune regulator from the intrauterine period and across development.
    MeSH term(s) Adolescent ; Adult ; Bipolar Disorder/complications ; Bipolar Disorder/genetics ; Bipolar Disorder/immunology ; Case-Control Studies ; Ethnic Groups/genetics ; Female ; France ; Gene Frequency/genetics ; Genetic Predisposition to Disease/genetics ; HLA-G Antigens/genetics ; HLA-G Antigens/immunology ; Humans ; INDEL Mutation/genetics ; Male ; Middle Aged ; Polymorphism, Single Nucleotide/genetics ; Toxoplasma ; Toxoplasmosis/complications ; Young Adult
    Chemical Substances HLA-G Antigens
    Language English
    Publishing date 2018-05-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 632565-8
    ISSN 1532-4311 ; 0882-0139
    ISSN (online) 1532-4311
    ISSN 0882-0139
    DOI 10.1080/08820139.2018.1469649
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Activation of Persulfate for Improved Naproxen Degradation Using FeCo2O4@g‑C3N4 Heterojunction Photocatalysts

    Baskaran Palanivel / Md Shahadat Hossain / Chinnadurai Ayappan / Vignesh Krishnan / Raj Marnadu / Thirunavukarasu Kalaivani / Fahad A Alharthi / Gedi Sreedevi

    ACS Omega, Vol 6, Iss 50, Pp 34563-

    2021  Volume 34571

    Keywords Chemistry ; QD1-999
    Language English
    Publishing date 2021-12-01T00:00:00Z
    Publisher American Chemical Society
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Book: Cell death regulation by BH3 only family proteins

    Chinnadurai, Govindaswamy

    (Oncogene ; 27, Suppl. 1 : Reviews)

    2008  

    Title variant Cell death regulation by BH3-only family proteins
    Author's details guest ed.: G. Chinnadurai
    Series title Oncogene ; 27, Suppl. 1 : Reviews
    Collection
    Language English
    Size S175 S. : Ill., graph. Darst.
    Publisher Nature Publ. Group
    Publishing place New York, NY
    Publishing country United States
    Document type Book
    HBZ-ID HT016054019
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  4. Book: CtBP family proteins

    Aihara, Hitoshi / Chinnadurai, Govindaswamy

    (Molecular biology intelligence unit)

    2007  

    Author's details G. Chinnadurai [ed. Contrib. Hitoshi Aihara ...]
    Series title Molecular biology intelligence unit
    Keywords DNA-Binding Proteins ; Phosphoproteins ; Transcription, Genetic
    Language English
    Size IX, 121 S. : Ill.
    Publisher Landes Bioscience ; Springer
    Publishing place Georgetown, Tex ; New York, NY
    Publishing country United States
    Document type Book
    HBZ-ID HT015378616
    ISBN 978-0-387-39971-3 ; 0-387-39971-2
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  5. Article ; Online: Editorial: Next generation MSC therapy manufacturing, potency and mechanism of action analysis.

    Chinnadurai, Raghavan / Viswanathan, Sowmya / Moll, Guido

    Frontiers in immunology

    2023  Volume 14, Page(s) 1192636

    MeSH term(s) Immunomodulation ; Mesenchymal Stem Cells
    Language English
    Publishing date 2023-04-21
    Publishing country Switzerland
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1192636
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Drug Delivery and Safety Considerations.

    Johnson, James G / Chinnadurai, Sathya K

    The veterinary clinics of North America. Exotic animal practice

    2021  Volume 25, Issue 1, Page(s) 1–11

    Abstract: Anesthetic drugs must be delivered at the appropriate dose and route of administration to produce the expected anesthetic effects. This is important for patient safety because anesthetic drugs function by depressing the central nervous and cardiovascular ...

    Abstract Anesthetic drugs must be delivered at the appropriate dose and route of administration to produce the expected anesthetic effects. This is important for patient safety because anesthetic drugs function by depressing the central nervous and cardiovascular systems, which if improperly dosed or administered could cause potentially life-threatening effects. Several routes of administration and different drug delivery methods are available to safely and reliably anesthetize zoologic companion animal patients. Because of the nature of zoologic companion animal practice, anesthetic procedures pose risks that the anesthetist should understand to carefully plan procedures that are as safe and efficient as possible.
    MeSH term(s) Anesthetics/adverse effects ; Animals ; Pharmaceutical Preparations
    Chemical Substances Anesthetics ; Pharmaceutical Preparations
    Language English
    Publishing date 2021-11-25
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 1558-4232
    ISSN (online) 1558-4232
    DOI 10.1016/j.cvex.2021.08.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Neuro-Ophthalmic Presentations of Adult-Onset Sinus Pericranii.

    Younes, Sami / Raviskanthan, Subahari / Mortensen, Peter W / Diaz, Orlando / Chinnadurai, Ponraj / Malik, Amina / Lee, Andrew G

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

    2024  

    Language English
    Publishing date 2024-01-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1189901-3
    ISSN 1536-5166 ; 1070-8022
    ISSN (online) 1536-5166
    ISSN 1070-8022
    DOI 10.1097/WNO.0000000000002091
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A Passivation-Free Solid Electrolyte Interface Regulated by Magnesium Bromide Additive for Highly Reversible Magnesium Batteries.

    Chinnadurai, Deviprasath / Lieu, Wei Ying / Kumar, Sonal / Yang, Gaoliang / Li, Yuanjian / Seh, Zhi Wei

    Nano letters

    2023  Volume 23, Issue 4, Page(s) 1564–1572

    Abstract: Highly reversible Mg battery chemistry demands a suitable electrolyte formulation highly compatible with currently available electrodes. In general, conventional electrolytes form a passivation layer on the Mg anode, requiring the use of ... ...

    Abstract Highly reversible Mg battery chemistry demands a suitable electrolyte formulation highly compatible with currently available electrodes. In general, conventional electrolytes form a passivation layer on the Mg anode, requiring the use of MgCl
    Language English
    Publishing date 2023-02-07
    Publishing country United States
    Document type Journal Article
    ISSN 1530-6992
    ISSN (online) 1530-6992
    DOI 10.1021/acs.nanolett.3c00033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Opposing oncogenic activities of small DNA tumor virus transforming proteins.

    Chinnadurai, G

    Trends in microbiology

    2011  Volume 19, Issue 4, Page(s) 174–183

    Abstract: The E1A gene of species C human adenovirus is an intensely investigated model viral oncogene that immortalizes primary cells and mediates oncogenic cell transformation in cooperation with other viral or cellular oncogenes. Investigations using E1A ... ...

    Abstract The E1A gene of species C human adenovirus is an intensely investigated model viral oncogene that immortalizes primary cells and mediates oncogenic cell transformation in cooperation with other viral or cellular oncogenes. Investigations using E1A proteins have illuminated important paradigms in cell proliferation and about the functions of cellular proteins such as the retinoblastoma protein. Studies with E1A have led to the unexpected discovery that E1A also suppresses cell transformation and oncogenesis. Here, I review our current understanding of the transforming and tumor-suppressive functions of E1A, and how E1A studies led to the discovery of a related tumor-suppressive function in benign human papillomaviruses. The potential role of these opposing functions in viral replication in epithelial cells is also discussed.
    MeSH term(s) Adenoviridae/pathogenicity ; Adenovirus E1A Proteins/metabolism ; Humans ; Oncogene Proteins, Viral/metabolism ; Tumor Suppressor Proteins/metabolism ; Virulence Factors/metabolism
    Chemical Substances Adenovirus E1A Proteins ; Oncogene Proteins, Viral ; Tumor Suppressor Proteins ; Virulence Factors
    Language English
    Publishing date 2011-02-15
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1158963-2
    ISSN 1878-4380 ; 0966-842X
    ISSN (online) 1878-4380
    ISSN 0966-842X
    DOI 10.1016/j.tim.2011.01.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Maintaining Renin-Angiotensin-Aldosterone System Inhibitor Treatment with Patiromer in Hyperkalaemic Chronic Kidney Disease Patients: Comparison of a Propensity-Matched Real-World Population with AMETHYST-DN.

    Chinnadurai, Rajkumar / Rengarajan, Sharmilee / Budden, Jeffrey J / Quinn, Carol Moreno / Kalra, Philip A

    American journal of nephrology

    2023  Volume 54, Issue 9-10, Page(s) 408–415

    Abstract: ... 5.0 mEq/L), and hypertension to receive patiromer, 8.4-33.6 g/day for 12 months. Patients underwent ...

    Abstract Introduction: Guideline-directed renin-angiotensin-aldosterone system inhibitor (RAASi) therapy is rarely achieved in clinical settings, often due to hyperkalaemia. We assessed the potassium binder, patiromer, on continuation of RAASi therapy in hyperkalaemic patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) in the AMETHYST-DN trial, propensity score-matched to a real-world cohort not receiving patiromer (Salford Kidney Study).
    Methods: The phase 2, open-label AMETHYST-DN trial (NCT01371747) randomized 304 adults with CKD on RAASi, T2DM, hyperkalaemia (serum potassium [sK+] >5.0 mEq/L), and hypertension to receive patiromer, 8.4-33.6 g/day for 12 months. Patients underwent propensity score matching for systolic blood pressure (BP), heart failure status, and estimated glomerular filtration rate (eGFR), with 321 patients with CKD, T2DM, hyperkalaemia, and on RAASi from a prospective CKD cohort (Salford Kidney Study). Changes in RAASi utilization, sK+, BP, proteinuria, and eGFR during 12-month follow-up were assessed by Mann-Whitney U or χ2 tests.
    Results: Matching produced 135:135 patients with no significant differences in age, sex, systolic BP, sK+, eGFR, or heart failure status, although differences in diastolic BP remained (p < 0.001). After 12 months, 100% of AMETHYST-DN patients receiving patiromer remained on RAASi therapy, whereas 38.5% of the Salford Kidney Cohort discontinued RAASi (p < 0.001); hyperkalaemia contributed in 16% of patients (42% of RAASi discontinuations). Significantly greater reductions in sK+ and BP, but not proteinuria or eGFR, were observed in AMETHYST-DN, compared with Salford Kidney Study patients (p < 0.05).
    Conclusions: These results demonstrate the benefit of patiromer for sK+ management to enable RAASi use while revealing beneficial effects on BP.
    MeSH term(s) Adult ; Humans ; Aldosterone ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Antihypertensive Agents/therapeutic use ; Diabetes Mellitus, Type 2/drug therapy ; Enzyme Inhibitors/therapeutic use ; Heart Failure ; Hyperkalemia/drug therapy ; Hyperkalemia/etiology ; Potassium ; Prospective Studies ; Renal Insufficiency, Chronic ; Renin-Angiotensin System
    Chemical Substances Aldosterone (4964P6T9RB) ; Angiotensin-Converting Enzyme Inhibitors ; Antihypertensive Agents ; Enzyme Inhibitors ; patiromer (1FQ2RY5YHH) ; Potassium (RWP5GA015D)
    Language English
    Publishing date 2023-09-19
    Publishing country Switzerland
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 604540-6
    ISSN 1421-9670 ; 0250-8095
    ISSN (online) 1421-9670
    ISSN 0250-8095
    DOI 10.1159/000533753
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top